Clinical Outcomes and Their Prognostic Factors among Cervical Cancer Patients with Bone Recurrence

Table 1

Clinical characteristics of study patients diagnosed with bone recurrence cervical cancer.

Characteristic	n	(%)
FIGO (2009)
I	10	10.20
II	39	39.80
III	42	42.90
IV	7	7.10
Histopathologic diagnosis
Squamous cell carcinoma	81	82.60
Adenocarcinoma	11	11.20
Adenosquamous carcinoma	3	3.10
Other
Primary treatment
Radiation	45	45.90
Concurrent chemoradiation	47	48.00
Surgery	6	6.10
Symptomatic
No	5	5.10
Yes	93	94.90
Investigation
Plain radiography	12	12.20
Skeletal scintigraphy	69	70.40
Computer tomography	50	51.00
Magnetic resonance imaging	28	28.60
Tissue biopsy	8	8.20
Tumor spread
Solitary	61	62.24
Multiple	37	37.76
Site of bone recurrence
Pelvis	12	12.24
Nonpelvis	72	73.47
Both	14	14.29
Coexisting recurrence
No	42	42.86
Yes	56	57.14
Organs with coexisting recurrence
Lymph nodes	38	38.90
Lungs	18	18.40
Liver	17	17.30
Brain	1	1.00
Combination	18	18.40
Treatment of bone recurrence
Radiation	54	54.10
Chemotherapy	7	7.14
Radiation-chemotherapy	14	14.29
Supportive care	20	20.41
Surgery with radiation with chemotherapy	3	3.06
Leukocyte count (μL)
<10000	29	29.60
≥10000	69	70.40
Hemoglobin (g/dL)
<11	42	42.90
≥11	56	57.10
Platelet count (μL)
<400000	32	32.70
≥400000	66	67.30

FIGO stage, International Federation of Gynecology and Obstetrics Staging System 2009.